Response to letter to the editor: ‘Gonadal tumour screening in XY gonadal dysgenesis’-Reference-Cited by-同舟云学术

Response to letter to the editor: ‘Gonadal tumour screening in XY gonadal dysgenesis’

Published:2024-03-12 Issue:5 Volume:100 Page:466-467
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clinical Endocrinology

Author:

Hannema Sabine E.¹²³⁴^ORCID,Wolffenbuttel Katja P.¹⁵,van Bever Yolande¹⁶,Bruggenwirth Hennie T.¹⁶,Hersmus Remko¹⁷,Oosterhuis J. Wolter¹⁷⁸,Looijenga Leendert H. J.¹⁷⁸

Affiliation:

1. Erasmus MC, Sophia Children's Hospital, University Medical Center Rotterdam, DSD‐Expert Center Rotterdam the Netherlands

2. Department of Pediatric Endocrinology Erasmus MC, University Medical Center Rotterdam the Netherlands

3. Department of Pediatrics Leiden University Medical Center Leiden the Netherlands

4. Department of Paediatric Endocrinology Amsterdam UMC Location Vrije Universiteit Amsterdam Amsterdam the Netherlands

5. Department of Urology and Pediatric Urology Erasmus MC, University Medical Center Rotterdam the Netherlands

6. Department of Clinical Genetics Erasmus MC, University Medical Center Rotterdam Rotterdam the Netherlands

7. Department of Pathology Erasmus MC, University Medical Center Rotterdam Rotterdam the Netherlands

8. Department of Pathology Princess Máxima Center for Pediatric Oncology, University Medical Center Utrecht Utrecht The Netherlands

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cen.15039

Reference2 articles.

1. BarbarB De SilvaN CheethamT WoodC QuintonR.Gonadal tumour screening in XY gonadal dysgenesis.Clin Endocrinol. Published online January 27 2024.doi:10.1111/cen.15015

2. Undetectable anti‐Mullerian hormone and inhibin B do not preclude the presence of germ cell tumours in 45,X/46,XY or 46,XY gonadal dysgenesis